SG47483A1 - A stabilized pharmaceutical formulation comprising growth hormone and histidine - Google Patents

A stabilized pharmaceutical formulation comprising growth hormone and histidine

Info

Publication number
SG47483A1
SG47483A1 SG1996002189A SG1996002189A SG47483A1 SG 47483 A1 SG47483 A1 SG 47483A1 SG 1996002189 A SG1996002189 A SG 1996002189A SG 1996002189 A SG1996002189 A SG 1996002189A SG 47483 A1 SG47483 A1 SG 47483A1
Authority
SG
Singapore
Prior art keywords
histidine
pharmaceutical formulation
growth hormone
stabilized pharmaceutical
stabilized
Prior art date
Application number
SG1996002189A
Other languages
English (en)
Inventor
Hans Holmegaard Soerensen
Lars Skriver
Annie Rassing Holegaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of SG47483A1 publication Critical patent/SG47483A1/en

Links

SG1996002189A 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine SG47483A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK204691A DK204691D0 (da) 1991-12-20 1991-12-20 Hidtil ukendt farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
SG47483A1 true SG47483A1 (en) 1998-04-17

Family

ID=8109688

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996002189A SG47483A1 (en) 1991-12-20 1992-12-16 A stabilized pharmaceutical formulation comprising growth hormone and histidine

Country Status (4)

Country Link
DK (1) DK204691D0 (da)
PL (1) PL171356B1 (da)
SG (1) SG47483A1 (da)
ZA (1) ZA929825B (da)

Also Published As

Publication number Publication date
ZA929825B (en) 1993-06-23
DK204691D0 (da) 1991-12-20
PL171356B1 (pl) 1997-04-30

Similar Documents

Publication Publication Date Title
IL116923A0 (en) Compounds with growth hormone releasing properties and pharmaceutical compositions containing them
IL102777A0 (en) Pharmaceutical combination formulation
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
EP0503301A3 (en) Peptide derivatives and application thereof
EP0498268A3 (en) 5-oxo-l-proline derivatives and pharmaceutical use thereof
NZ228096A (en) A parenteral pharmaceutical formulation stabilised against aggregation comprising human growth hormone, glycine and mannitol
AU7324391A (en) A method and device for local administration of biologically active substances
GB9114950D0 (en) Pharmaceutical formulation
IL101010A0 (en) Steroid pharmaceutical formulations
AU3949093A (en) A pharmaceutical formulation
SG47483A1 (en) A stabilized pharmaceutical formulation comprising growth hormone and histidine
IL122519A0 (en) Stabilized pharmaceutical compositions comprising a growth hormone and a peptide
AU5997196A (en) A stabilized pharmaceutical formulation comprising growth ho rmone and lys-gly-asp-ser
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
GB9216061D0 (en) Pharmaceutical combination formulation
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone
NZ268125A (en) Growth hormone pharmaceutical composition
HU9203050D0 (en) Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them
AU4292993A (en) Improved delivery formulation for lipophilic drugs
AU617427C (en) Pharmaceutical growth hormone formulations
ZA922695B (en) Precursor form of bovine growth hormone releasing factor and related DNA compounds
GB9109866D0 (en) Fluffed portion preparation device
AUPM375994A0 (en) Stabilised growth hormone formulation
GB9104064D0 (en) Peptide compound and its preparation